CME Group (NASDAQ:CME) PT Lowered to $193.00 at Deutsche Bank Aktiengesellschaft

CME Group (NASDAQ:CME) had its price objective cut by equities researchers at Deutsche Bank Aktiengesellschaft from $195.00 to $193.00 in a research note issued on Thursday, Benzinga reports. The brokerage presently has a “hold” rating on the financial services provider’s stock. Deutsche Bank Aktiengesellschaft’s target price would indicate a potential downside of 3.68% from the company’s current price.

A number of other brokerages also recently weighed in on CME. Bank of America upped their price target on shares of CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a report on Thursday, April 25th. Keefe, Bruyette & Woods increased their price objective on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday. Barclays boosted their target price on CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research report on Thursday. Rosenblatt Securities reaffirmed a “sell” rating and set a $187.00 price objective (up from $185.00) on shares of CME Group in a research note on Thursday, April 25th. Finally, JPMorgan Chase & Co. lifted their target price on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $212.64.

CME Group Price Performance

Shares of CME Group stock traded up $3.12 on Thursday, hitting $200.37. The company had a trading volume of 914,300 shares, compared to its average volume of 1,960,367. CME Group has a 52 week low of $190.70 and a 52 week high of $223.80. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.01. The company has a market cap of $72.15 billion, a PE ratio of 22.73, a PEG ratio of 6.56 and a beta of 0.52. The business has a 50-day simple moving average of $200.38 and a 200-day simple moving average of $206.98.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period last year, the company posted $2.30 EPS. The firm’s quarterly revenue was up 12.7% on a year-over-year basis. Research analysts expect that CME Group will post 9.77 EPS for the current fiscal year.

Insider Activity at CME Group

In other CME Group news, CEO Terrence A. Duffy sold 40,000 shares of the company’s stock in a transaction dated Monday, April 29th. The stock was sold at an average price of $210.91, for a total value of $8,436,400.00. Following the transaction, the chief executive officer now directly owns 67,455 shares of the company’s stock, valued at approximately $14,226,934.05. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, CEO Terrence A. Duffy sold 40,000 shares of the stock in a transaction on Monday, April 29th. The shares were sold at an average price of $210.91, for a total transaction of $8,436,400.00. Following the transaction, the chief executive officer now owns 67,455 shares in the company, valued at approximately $14,226,934.05. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Charles P. Carey sold 3,000 shares of the firm’s stock in a transaction on Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the transaction, the director now owns 7,163 shares in the company, valued at approximately $1,399,936.72. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 54,290 shares of company stock valued at $11,393,700. Insiders own 0.30% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in CME. Norges Bank acquired a new position in CME Group during the fourth quarter valued at approximately $959,260,000. Capital International Investors boosted its holdings in shares of CME Group by 24.1% during the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after buying an additional 3,069,806 shares during the period. PineStone Asset Management Inc. grew its stake in CME Group by 137.6% in the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock valued at $444,443,000 after buying an additional 1,309,097 shares during the last quarter. Capital Wealth Planning LLC acquired a new position in CME Group during the 4th quarter worth $253,563,000. Finally, Capital World Investors boosted its holdings in CME Group by 8.7% during the fourth quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after acquiring an additional 1,172,575 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.